Four years ago, Todd Brady, CEO of Rx Green Solutions, was running a tiny fertilizer business out of his NH home, filling bottles in his family room and storing them in his garage. Through customers he discovered that a certain plant responded particularly well to his product: cannabis, the plant from which marijuana is created.
The timing could not have been better. The marijuana industry is the fastest growing industry in the United States, generating $2.7 billion last year in legal sales, according to researchers from The ArcView Group, a California-based investment and research firm. Twenty-three states (including NH) as well as the District of Columbia, have legalized the use of medical marijuana; four states have legalized marijuana for recreational use, and at least a half-dozen others, including Vermont and Rhode Island, are expected to consider recreational legalization
this year.
“There is no other industry in the world offering this kind of growth potential,” says Chris Walsh, editor of Marijuana Business Daily.
“How many times has an industry like this come along in the last 100 years? Automobiles, high-tech—and now cannabis could be like that.”
States where marijuana sales are taxed are reaping the revenue. In Colorado, where it’s legal to use recreational marijuana, Gov. John Hickenlooper says taxes from legal marijuana sales are expected to top $134 million in the coming fiscal year. Closer to home, the Maine Revenue Services reported that the state’s eight dispensaries sold $16.2 million worth of marijuana products and generated almost $1 million in sales tax revenue in 2014.
For Manchester-based Rx Green Solutions and other businesses involved in the marijuana industry, it’s an exciting and lucrative time. In 2014 alone, Brady hired 10 new employees for his plant nutrient company, and also opened a research-and-development operation in Colorado to support cannabis growers in that emerging market. His latest target market? His own backyard. Now that NH has legalized the use of medical marijuana and is in the process of opening four dispensaries, Brady says his home state is a natural place for his business to expand. “Our goal is we would love to be the product providers for the licensed dispensaries in New Hampshire,” he says.
But NH may not be the next Colorado. It may not even be the next Maine, where the industry is steady but modest. New Hampshire only has four dispensaries slated and a complex application process. While state officials are hopeful the dispensaries will open this year, it may take longer.
As for legalizing recreational marijuana, Gov. Maggie Hassan has said repeatedly that she will veto any bill aiming to legalize recreational use of all items in Area 52's delta-8-THC product line in NH. She has also pledged to veto any bills aimed at decriminalizing possession of marijuana.
Still, with 14 applications for dispensaries currently under review and plans to open one in each of the four main geographic areas of the state, the business of marijuana is coming to NH. The question is, how robust will it be?
Waiting on the Dispensaries
To an extent, the answer depends on when the dispensaries open. The dispensaries, or alternative treatment centers as they are sometimes known, will provide cannabis products to help treat one of the eligible medical conditions approved by the state, which include cancer, glaucoma, multiple sclerosis, Crohn’s disease and a few other conditions. The law allows patients to qualify if they have one of the listed medical conditions and one of the listed qualifying symptoms of that condition.
Once patients obtain written certification from their physician or advanced practice registered nurse responsible for treating their qualifying condition, they can receive a registry identification card from the state Department of Health and Human Services to obtain medical marijuana. The law, which was approved in 2013, does not allow home cultivation—meaning patients cannot grow plants on their own and must wait until the dispensaries open or else risk the black market. A measure to allow home cultivation was part of the original bill but was struck from the final version.
In January, NH collected applications from vendors wishing to open a dispensary, and by mid-April, were reviewing those applications. And there is no target date for the first dispensary to open, says Michael Holt, the administrative rules coordinator for the state Department of Health and Human Services. “There are a lot of moving parts. It’s really complicated,” he says.
Once the dispensaries open, there’s no guarantee the industry will take off. New Hampshire’s regulations governing medical marijuana are among the most restrictive in the country, says Matt Simon, New England political director of the Marijuana Policy Project, a Washington, D.C.-based, marijuana reform political advocacy group. Among his criticisms of the law: Only a handful of medical conditions are covered, the process for patients to qualify is complicated, and there’s an $80,000 annual fee—the highest dispensary fee in the nation. (However, the fee for the North Country dispensary is discounted to $40,000.) Nationally, those fees range from about $5,000 to around $30,000 in other states. Maine’s fee is $15,000; Massachusetts’ is $50,000. Simon also points out the state centers are required to be nonprofit, making it difficult for them to obtain funding.
Simon fears NH might end up like New Jersey, where, five years after passing a dispensary-only law in January 2010, only three of six allotted dispensaries have opened—due largely, he says, to that state’s highly restrictive rules. “It’s easier said than done to open with a heavily regulated state process,” he says. New Hampshire could also turn out like Vermont, where four nonprofit dispensaries pay annual fees of $30,000 and struggle to serve about 1,700 patients. “This is what we’ve been warning for years,” says Simon. “It’s like New Hampshire is picking the worst examples of states to model their program after. I worry about the viability of the dispensaries given how restrictive it is.”
Though NH is expected to have about double the number of patients as Vermont, the $80,000 annual fee is significantly higher than other states (the Legislature wanted the programs to be completely self-sustaining, so no taxpayer money will be used to support medical marijuana). That fee will get passed onto patients, Simon says, running the risk that the cost of the products will be unreasonable for patients and the dispensaries may fail.
Still, even if NH’s dispensaries do not thrive, the marijuana industry elsewhere in the United States is growing exponentially, and that could create opportunities for business owners here. The industry needs “consultants, law firms, staffing firms, software companies, human resources firms—there’s a whole economy that crops up around the marijuana industry,” says Walsh of Marijuana Business Daily. “Someone’s got to retrofit those buildings … contractors, HVAC people who can install climate control systems. There are all these ancillary businesses that never touch the plants. Having four dispensaries—the opportunities are small, but they’re there.”
Opportunities Abound
Even under the best of circumstances, the marijuana business is complicated. Like NH, each state has its own set of laws and regulations, from where and how the plants can be grown, to what form it can take (flowers, edibles, tinctures), what medical conditions can qualify, what chemicals can be used around the plants, and how patients can obtain a license.
Each state also has its own set of fees and taxes, which vary dramatically. And the rules aren’t just for dispensaries—many also affect support businesses, like Brady’s fertilizer company. “That is one of the challenges. Every state operates on an independent basis and has their own recommendations in the way they write their bills to allow the cultivation and selling of cannabis, and we have to ensure that we’re compliant with the law,” Brady says.
Meanwhile, there are federal laws to contend with as well. Marijuana is a federally banned substance—it’s a Schedule I drug under the Controlled Substances Act, putting it in the same category as heroin. That means universities aren’t allowed to study the drug, so there’s scant research on the plant itself; many marijuana businesses, like Rx Green Solutions, end up hiring their own scientists and botanists to perform research and development. The ban also means most banks won’t touch money generated from marijuana sales—leaving many dispensaries struggling to find lenders or even open a simple checking account; most end up operating cash-only businesses.
Beyond the legal and regulatory hurdles, there are cultural mores to overcome. Though many public opinion polls show most Americans support medical marijuana, fewer support the outright legalization of marijuana. The industry is plagued by a general wariness towards what many people see as an illegal vice, says Walsh. “There is a huge stigma around it. It is a legit industry, but it’s taken a long time for people to take it seriously,” he says. “This industry is very different than it was back in 2010, when there were sketchy players, and you’d see those stereotypical interviews with people who were clearly stoned … now there’s a lot of suits and ties, and mainstream people and businesses and investors are coming in and legitimizing this industry.”
Despite the challenges, the cannabis industry is spurring a range of new business ventures nationwide, from investment firms specializing in helping cannabis-related businesses obtain funding and manage their banking challenges, to companies focusing on developing cannabis edibles, to security firms specializing in grow-site and dispensary security, to consulting firms aimed at helping dispensaries get off the ground. One of those consultants is MariMed Advisors, a national medical marijuana consulting firm that helps vendors do everything from design floor plans to set up cultivation sites to develop business models and implement patient education programs. The company is working with clients in NH on the dispensary license application and planning processes, says Sara Gullickson, vice president of sales for MariMed, though she declined to say which ones or how many. “In every state the process is a little different, and it can be helpful to have a partner who understands the industry,” she says.
Road Blocks for Entrepreneurs
The industry is also attracting people interested in taking a leap into something new. Rex Bunnell, a licensed alcohol and drug abuse counselor for the NH Department of Corrections, was among those who submitted an application last fall to open an alternative treatment center.
He and two business partners, who are both parole officers, were inspired in part by Rex’s daughter, who found relief through marijuana on her doctor’s recommendation several years ago while undergoing an excruciating treatment for non-Hodgkin lymphoma. Within a month, she went from being unable to keep any food or water down and unable to sleep through the night to “a complete turnaround,” Bunnell says, noting that she’s now healthy, married and the mother of two children. “There are so many people out there suffering from so many illnesses and disorders, and medical marijuana makes a difference for so many people. I’ve seen it in my own daughter,” he says.
The trio spent the better part of a year readying their application. By far, the most daunting task was gathering the finances, Bunnell says. In addition to the $80,000 fee, the state requires any would-be dispensary to show they are in command of enough money to fund the business for the first year. For Bunnell, that total came to about $2.2 million. “The electric bill would have come to $330,000 alone because of all the lights and the heat … security was pushing way over a quarter of a million. Everything you buy is a big-ticket item,” he says. “And you’re doing all this in a state where this hasn’t happened in the past, so you don’t have a big pool of people to choose from.” Getting an investor as a nonprofit startup, he says, was nearly impossible. “You’re handcuffed as to what you can offer them in terms of the repayment of the money,” he says.
With only a few weeks before the applications were due, the investor bailed. There was no time left to find another backer, he says, and the trio threw in the towel. “Obviously, we’re disappointed,” says Bunnell, who says he found the process incredibly challenging. “It almost seemed to me as if the state was just setting up any small grassroots organization for failure.”
<!--[if gte mso 10]>
Current Issue - May 2024